Latest News about Geoffrey Porges
Recent news which mentions Geoffrey Porges
From Benzinga
From Benzinga
From Benzinga
Vertex shuts down trial of liver drug, spurring a selloff
October 15, 2020
From Business Journals
From Benzinga
From Benzinga
Pfizer Analysts See 'Surprisingly Strong' Vaccine Updates In Q2, Question Biopharma's Blockbuster Potential
July 29, 2020
From Benzinga
Moderna Looking To Price Its Coronavirus Vaccine At $50-$60, Significantly Above Rivals: FT
July 28, 2020
From Benzinga
Moderna Analysts See Positives In Coronavirus Readout As Focus Shifts To Pivotal Phase 3 Study
July 15, 2020
From Benzinga
From Benzinga
Will anything come of AstraZeneca's rumored interest in merging with Gilead? Not likely
June 08, 2020
From Business Journals
From Business Journals
From Benzinga
From Business Journals
From Business Journals
From Business Journals
From Business Journals
From Business Journals
From Business Journals
From Business Journals
AbbVie Shares Double In A Year; Leerink Moves To Sidelines
January 29, 2018
From Benzinga
Analyst names Vertex and Alexion 'top picks for 2018'
January 02, 2018
From Business Journals
Plenty Of Opportunity In AbbVie, Even After Recent Run
October 02, 2017
From Benzinga
43% Upside Seen For Dova Pharma Following Competitor Product's Poor Results
September 26, 2017
Tickers
DOVA
From Benzinga
Vertex’s latest FDA nod could boost sales by $150M: analyst
August 02, 2017
From Business Journals
Sarepta hikes full-year sales estimate for Duchenne drug
July 19, 2017
From Business Journals
Tickers
BIIB
From Business Journals
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.